FDA Updates Hydrochlorothiazide Label for Nonmelanoma Skin Cancer
Hydrochlorothiazide is associated with an increased risk of nonmelanoma skin cancer, according to updates to the medication’s label.
Related Articles
Advancements in Breast Cancer Treatment | PBCC 2024
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…
Advancements in Breast Cancer Treatment | PBCC 2024
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…
Home
Thursday, May 30, 2024 | 12:00 pm – 12:30 pm ET Supported by an independent educational grant from BioMarin. Join us for a live webinar…
Advancements in Breast Cancer Treatment | PBCC 2024
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…
The role of oral SERDs as second-line therapy for patients with ER-positive/HER2-negative MBC
You don’t want to miss this LIVE 30-minute social media event with Drs. Aditya Bardia, Kevin Kalinsky, and Lesley Fallowfield, who will discuss the role…
Home
San Diego Mission Bay Resort San Diego, California For 27 years, the Acute Leukemia Forum (ALF) has provided a unique platform that enables the world’s…
Home
San Diego Mission Bay Resort San Diego, California For 27 years, the Acute Leukemia Forum (ALF) has provided a unique platform that enables the world’s…
Home
San Diego Mission Bay Resort San Diego, California For 27 years, the Acute Leukemia Forum (ALF) has provided a unique platform that enables the world’s…
Are Multicancer Early Detection Tests More Hype Than Help?
New tests that detect multiple cancers with a single blood draw promise to revolutionize cancer screening, but they have also raised many unanswered questions.
Transcatheter Arterial Chemoembolization for Rectal Tumors?
Chinese investigators have applied a technique long used for liver metastases to rectal cancer, with promising results.